Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
|Articles|July 1, 2020
- Pharmaceutical Technology Buyers' Guide 2020
- Volume 2020 Special Issue
Pharmaceutical Technology 2020 Buyers' Guide
Find connections to suppliers of the materials, equipment, and services you need to develop, manufacture, and distribute crucial therapies, treatments, and vaccines in the 2020 Pharmaceutical Technology Buyers' Guide.
Advertisement
Pharmaceutical Technology’s annual Buyers’ Guide is the leading directory of thousands of suppliers of ingredients, materials, and other resources needed for the development and manufacture of solid dose, parenteral, biologic, inhalation, transdermal, and other drug forms.
Use the following links for fast reference to specific technologies and services:
Chemicals, raw materials, intermediates, and excipients Manufacturing equipment and supplies Cleanroom equipment and supplies Packaging equipment and accessories Laboratory equipment and supplies Information technologies Outsourcing services .
In addition, read about trends and innovations in the guide’s
For more online resources, visit the
Advertisement
Related to this article
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
Almac Clinical Services’ clinical supply strategy won the 2026 CPHI Award for Supply Chain Excellence. Nishma Patel, supply chain solutions manager, explains the benefits and challenges of the company’s just-in-time manufacturing solution.
CDMOs announced expansions, exhibitors showcased automated equipment, and supply chain strategy discussions were a focus at CPHI Milan 2026.
Mitigating nitrosamine risk requires assessing each product individually and chasing zero nitrite in pharmaceutical excipients is often impractical and costly.
This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
4
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
5